{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T01:45:38Z","timestamp":1768787138196,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.acvd.2014.01.010","type":"journal-article","created":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T01:46:07Z","timestamp":1394675167000},"page":"149-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Heart failure with systolic dysfunction complicating acute myocardial infarction\u00a0\u2013\u00a0differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial"],"prefix":"10.1016","volume":"107","author":[{"given":"Sylvain","family":"Carillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Fay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Angioi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh C.","family":"Sutradhor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2014.01.010_bib0005","doi-asserted-by":"crossref","first-page":"113e2","DOI":"10.1016\/j.ahj.2010.10.004","volume":"161","author":"Chin","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0010","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/jama.297.17.1892","article-title":"Decline in rates of death and heart failure in acute coronary syndromes, 1999\u20132006","volume":"297","author":"Fox","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2014.01.010_bib0015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/01.CIR.0000109691.16944.DA","article-title":"Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global registry of acute coronary events (GRACE)","volume":"109","author":"Steg","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.01.010_bib0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1161\/CIRCULATIONAHA.108.789685","article-title":"Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure","volume":"118","author":"Steg","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.01.010_bib0025","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/01.CIR.0000113460.23813.50","article-title":"Acute heart failure complicating acute coronary syndromes: a deadly intersection","volume":"109","author":"Velazquez","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.01.010_bib0030","doi-asserted-by":"crossref","first-page":"13F","DOI":"10.1016\/j.amjcard.2006.03.005","article-title":"Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance","volume":"97","author":"Weir","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2014.01.010_bib0035","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1016\/j.ehj.2004.08.006","article-title":"An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry","volume":"25","author":"Velazquez","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0040","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0735-1097(02)02173-3","article-title":"Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National registry of myocardial infarction (NRMI-2)","volume":"40","author":"Wu","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.01.010_bib0045","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.amjcard.2007.02.083","article-title":"Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart Lung, and Blood Institute Dynamic Registry)","volume":"100","author":"Abbott","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2014.01.010_bib0050","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/eurheartj\/ehq326","article-title":"Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)","volume":"31","author":"Fox","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0055","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1093\/eurheartj\/ehl196","article-title":"The second Euro Heart Survey on acute coronary syndromes: characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean basin in 2004","volume":"27","author":"Mandelzweig","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0200","series-title":"The late consequences of acute coronary syndromes: 2-year follow-up outcomes, procedures and treatment of patients from the Global Registry of Acute Coronary Events (GRACE). Abstract 3963","author":"Goodman","year":"2011"},{"key":"10.1016\/j.acvd.2014.01.010_bib0065","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurheartj\/ehi002","article-title":"Mortality rates in patients with ST-elevation vs. non-ST-elevation acute myocardial infarction: observations from an unselected cohort","volume":"26","author":"Terkelsen","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0070","doi-asserted-by":"crossref","first-page":"4F","DOI":"10.1016\/j.amjcard.2006.03.004","article-title":"Cardiovascular effects of aldosterone and post-acute myocardial infarction pathophysiology","volume":"97","author":"Cohn","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.acvd.2014.01.010_bib0075","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2014.01.010_bib0080","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.01.010_bib0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.300.1.71","article-title":"Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis","volume":"300","author":"O\u2019Donoghue","year":"2008","journal-title":"JAMA"},{"issue":"suppl. L","key":"10.1016\/j.acvd.2014.01.010_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/eurheartj\/16.suppl_L.3","article-title":"Acute coronary thrombosis\u00a0\u2013\u00a0the role of plaque disruption and its initiation and prevention","volume":"16","author":"Davies","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0095","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJM199705013361809","article-title":"The composition of coronary-artery plaques","volume":"336","author":"Davies","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2014.01.010_bib0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/hrt.69.5.377","article-title":"Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content","volume":"69","author":"Davies","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0105","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","article-title":"Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology","volume":"29","author":"Van de Werf","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0110","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","article-title":"Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes","volume":"28","author":"Bassand","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0115","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jcin.2011.02.019","article-title":"Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial","volume":"4","author":"Goto","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2014.01.010_bib0120","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0706416","article-title":"Thrombus aspiration during primary percutaneous coronary intervention","volume":"358","author":"Svilaas","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2014.01.010_bib0125","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/eurjhf\/hfp151","article-title":"Heart failure in patients hospitalized with acute coronary syndromes: observations from the Gulf Registry of Acute Coronary Events (Gulf RACE)","volume":"11","author":"Alsheikh-Ali","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2014.01.010_bib0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2014.01.010_bib0135","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1388-9842(03)00112-0","article-title":"VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context","volume":"5","author":"Velazquez","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2014.01.010_bib0140","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/01.CIR.102.10.1193","volume":"102","author":"Braunwald","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.acvd.2014.01.010_bib0145","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0735-1097(99)00351-4","volume":"34","author":"Ryan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.01.010_bib0150","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1053\/euhj.2002.3193","article-title":"A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro heart survey of acute coronary syndromes (Euro Heart Survey ACS)","volume":"23","author":"Hasdai","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0155","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart failure survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0165","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(99)04021-0","article-title":"Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease","volume":"353","author":"Tunstall-Pedoe","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.acvd.2014.01.010_bib0170","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2008.07.030","article-title":"Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006","volume":"156","author":"Rogers","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.acvd.2014.01.010_bib0175","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jacc.2007.10.063","article-title":"Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis","volume":"51","author":"Setoguchi","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.acvd.2014.01.010_bib0180","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1463-1326.2007.00730.x","article-title":"Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS","volume":"10","author":"O\u2019Keefe","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.acvd.2014.01.010_bib0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/HYPERTENSIONAHA.107.109314","article-title":"History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure","volume":"52","author":"Pitt","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.acvd.2014.01.010_bib0190","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejheart.2005.11.008","article-title":"Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction<or=30%","volume":"8","author":"Pitt","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.acvd.2014.01.010_bib0195","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","article-title":"Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies","volume":"150","author":"Clarke","year":"1999","journal-title":"Am J Epidemiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213614000266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213614000266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:41:36Z","timestamp":1761745296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213614000266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S1875213614000266"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2014.01.010","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure with systolic dysfunction complicating acute myocardial infarction\u00a0\u2013\u00a0differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2014.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}